Deficient dietary intake of vitamin E in patients with taste and smell dysfunctions: Is vitamin E a cofactor in taste bud and olfactory epithelium apoptosis and in stem cell maturation and development?

Nutrition

Volumn 19, Issue 11-12, 2003, Pages 1013-1021

  Henkin, R I ^a   Hoetker, J D ^a  

^a Taste and Smell Clinic   (United States)

Author keywords

Apoptosis; Development; Growth; Olfactory epithelium; Sensory dysfunction; Sensory processes; Smell; Stem cells; Taste; Taste buds; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; COPPER; IRON; NICOTINIC ACID; PYRIDOXINE; THIAMINE; TRACE METAL; ZINC;

ADOLESCENT; ADULT; AGED; APOPTOSIS; CALORIC INTAKE; CARBOHYDRATE INTAKE; CELL MATURATION; CONTROLLED STUDY; FAT INTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OLFACTORY EPITHELIUM; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; SMELLING DISORDER; STEM CELL; TASTE BUD; TASTE DISORDER; VITAMIN INTAKE;

EID: 0242580242     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2003.08.006     Document Type: Article

References (147)

1. Henkin R.I. Evaluation and treatment of human olfactory dysfunction. English G.M. Otolaryngology, Vol 2. 1993;1 Lippincott, Philadelphia.
2. Henkin R.I. Concepts of therapy in taste and smell dysfunction repair of sensory receptor function as primary treatment . Kurihara K., Suzuki N., Ogawa H. Olfaction and taste, Vol XI. 1994;568 Springer-Verlag, Tokyo.
3. Henkin R.I. Human taste and smell disorders. Adelman G. Encyclopedia of neuroscience. 2nd ed. 1999;2010 Birkhauser, Boston.
4. Henkin R.I., Keiser H.R., Jaffe I.A., Sternlieb I., Scheinberg I.H. Decreased taste sensitivity after D-penicillamine reversed by copper administration. Lancet. II:1967;1268.
5. Keiser H.R., Henkin R.I., Bartter F.C., Sjoerdsma A. Loss of taste during therapy with penicillamine. JAMA. 203:1968;381.
6. Henkin RI. Trace metals and taste. In: Hemphill DD, ed. Trace substances in environmental health, Vol III. Columbia: University of Missouri Press, 1969;88.
7. Henkin R.I., Mueller C., Wolf R. Estimation of zinc concentration of parotid saliva by flameless atomic absorption spectrophotometry in normal subjects and in patients with idiopathic hypogeusia. J Lab Clin Med. 86:1975;175.
8. Henkin R.I., Patten B.M., Re P., Bronzert D. A syndrome of acute zinc loss. Arch Neurol. 32:1975;745.
9. Henkin R.I., Lippoldt R.E., Bilstad J., Edelhoch H. A zinc protein isolated from human parotid saliva. Proc Nat Acad Sci USA. 72:1975;488.
10. Henkin R.I., Martin B.M., Agarwal R.P. Decreased parotid saliva gustin/carbonic anhydrase VI secretion an enzyme disorder manifested by gustatory and olfactory dysfunction . Am J Med Sci. 318:1999;380.
11. Henkin R.I., Martin B.M., Agarwal R.P. Efficacy of exogenous zinc in treatment of patients with carbonic anhydrase VI deficiency. Am J Med Sci. 318:1999;392.
12. Henkin R.I., Bradley D.F. Hypogeusia corrected by Ni++ and Zn++. Life Sci. 9:1970;701.
13. Babior B.M., Bunn H.F. Megaloblastic anemias. Isselbacker K.J., Braumwald E., Wilson J.D., Martin J.B., Fauci A.S., Kasper D.L. Principles of internal medicine. 1994;1726 McGraw-Hill, New York.
14. Smith A.D.M. Megaloblastic madness. Br Med J. 2:1960;1840.
15. Beck W.S. Metabolic features of cobalamin deficiency in men. Babior B.M. Cobalamin biochemistry and pathophysiology. 1975;403 Wiley, New York.
16. Beck W.S. Neuropsychiatric consequences of cobalamine deficiency. Adv Int Med. 36:1991;33.
17. 12 absorption. Dan Med Bull. 12:1965;159.
18. 12 deficiency. J Am Geriatr Soc. 20:1972;93.
19. Lindenbaum J., Healton E.B., Savage D.G., et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 318:1989;1720.
20. Wilson JD. Vitamin deficiency and excess. In: Isselbacker KJ, Braumwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Principles of internal medicine. New York: McGraw-Hill, 1994:472.
21. Rundles R.W. Prognosis in the neurologic manifestation of pernicious anemia. Blood. 1:1946;209.
22. Henkin RI. unpublished observations.
23. Haas R.H. Thiamin and the brain. Annu Rev Nutr. 8:1988;483.
24. Jones B.P., Butters N.M., Moskowitz H.R., Montgomery K. Olfactory and gustatory capacities of alcoholic Korsakoff patients. Neuropsychologia. 16:1978;323.
25. Jones B.P., Moskowitz H.R., Butters N.M. Olfactory discrimination thalamus in alcoholic Korsakoff patients. Neuropsychologia. 13:1975;173.
26. Mizell C.C. The etiology, nosology and treatment of pellagra the drying linolein-bearing seed oils and the obstruction of sulphur as underlying causes . Am J Clin Med. 18:1911;1145.
27. Bean W.B., Franklin M., Dunn K. A note on tryptophane and pellagrous glossitis. J Lab Clin Med. 38:1951;167.
28. Green R.F. Subclinical pellagra and idiopathic hypogeusia. JAMA. 218:1971;1303.
29. Wald G. Molecular basis of visual excitation. Science. 162:1968;230.
30. Goodman D.S. Vitamin A and retinoids in health and disease. N Eng J Med. 310:1984;1023.
31. Duncan R.B., Briggs M.H. Treatment of uncomplicated anosmia by vitamin A. Arch Otolaryngol. 75:1962;36.
32. Bernard R.A., Halpern B., Kare M.R. Effect of vitamin A deficiency on taste. Proc Soc Exp Biol Med. 108:1962;784.
33. Bernard R.A., Halpern B.P. Taste changes in vitamin A deficiency. J Gen Physiol. 52:1968;444.
34. Henkin R.I., Schechter P.J., Hoye R.C., Mattern C.F.T. Idiopathic hypogeusia with dysgeusia, hyposmia and dysosmia a new syndrome . JAMA. 217:1971;4341.
35. Sitrin M.D., Lieberman F., Jensen W.E., Novonha A., Milburn C., Addington W., et al. Vitamin E deficiency and neurologic disease in adults with cystic fibrosis. Ann Intern Med. 107:1987;51.
36. Sokol R.J. Vitamin and neurologic function in man. Free Radic Biol Med. 6:1989;189.
37. vanDam P.S., vanAsbeck B.S., Bravenboer B., et al. Nerve function and oxidative stress in diabetic and vitamin E deficient rats. Free Radic Biol Med. 24:1997;18.
38. Tutuncu N.B., Bayraktor M., Varli K. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes. Diabetes Care. 21:1998;1915.
39. McCarron M.O., Russell A.J.C., Metcalfe R.A., Deysilva R. Chronic vitamin E deficiency causing spinocerebellar degeneration, peripheral neuropathy, and centrocecal scotomata. Nutrition. 15:1999;217.
40. Azzi A., Boscoboinik D., Maralley D., Özer N.K., Stäuble B. Vitamin E a sensor and an information transducer of the cell oxidation state . Am J Clin Nutr. 62:(suppl):1995;13375.
41. Enrione E.B., Weeks O.I., Kranz S., Shen J. A vitamin E-deficient diet affects nerve regeneration in rats. Nutrition. 15:1999;140.
42. Schubert D., Kimura H., Maker P. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Nat Acad Sci USA. 89:1992;8264.
43. Quinn P.J. Localization of vitamin E in membranes. Subcell Biochem Fat Solub Vitam. 30:1998;319.
44. Glanz K., Basil M., Maibach E., Goldberg D. Why Americans eat what they do taste, nutrition, cost, convenience and weight concerns on food consumption . J Am Diet Assoc. 98:1998;1118.
45. Henkin R.I., Gillis W.T. Divergent taste responsiveness to fruit of the tree Antidesma bunius. Nature. 265:1977;536.
46. Tepper B.J., Hartfiel L.M., Schneider S.H. Sweet taste and diet in type II diabetes. Physiol Behav. 60:1996;13.
47. Fischer R., Griffin F., Kaplan A. Taste threshold, cigarette smoking and food dislikes. Med Exp. 9:1963;151.
48. Duffy V., Backstrand J., Ferris A. Olfactory dysfunction and related nutritional risk in free-living, elderly women. J Am Diet Assoc. 95:1995;879.
49. Bowen D.J. Taste and food preference changes across the course of pregnancy. Appetite. 19:1992;233.
50. Tepper B.J., Seldner A.C. Sweet taste and intake of sweet foods in normal pregnancy and pregnancy complicated by gestational diabetes mellitus. Am J Clin Nutr. 70:1999;277.
51. Markley E.J., Mattes-Kulig D.A., Henkin R.I. A classification of dysgeusia. J Am Diet Assoc. 5:1983;578.
52. Mattes-Kulig D.A., Henkin R.I. Energy and nutrient consumption of patients with dysgeusia. J Am Diet Assoc. 85:1985;822.
53. Nutritionist IV dietary software, version. 4.5. San Bruno: N-squared Computing, 1994.
54. Traber M.G., Jialal I. Measurement of lipid-soluble vitamins-a further adjustment needed? Lancet. 355:2000;2013.
55. Thurnam D.I., Davies J.A., Cramp B.J., Situnayake R.D., Davis M. The use of different lipids to express serum tocopherol lipid ratios of the measurement of vitamin E status . Ann Clin Biochem. 23:1986;514.
56. Traber M.G. The bioavailability bugaboo. Am J Clin Nutr. 71:2000;1029.
57. Edwards C.H., McDonald S., Mitchell J.R., et al. Clay, and cornstarch eating women. J Am Diet Assoc. 35:1959;810.
58. Prasad A.S., Halsted J.A., Nadimi M. Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism, and geographia. Am J Med. 31:1961;532.
59. Podda M., Weber C., Traber M.G., Packer L. Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols and ubiquinones. J Lipid Res. 37:1996;893.
60. MacEvelly C.J., Muller D.P.R. Lipid peroxidation in neural tissues and fractions from vitamin E-deficient rats. Free Radic Biol Med. 20:1996;639.
61. Meydani M. Vitamin E. Lancet. 345:1995;170.
62. x and compliments α-tocopherol physiological implications . Proc Nat Acad Sci USA. 94:1997;3217.
63. Friedrichson T., Kalbach L.V., Buck P., VanKuijk F.J.G.M. Vitamin E in ocular and peripheral tissues of the human eye. Curr Eye Res. 14:1995;693.
64. Block F., Schwarz M. Effects of antioxidants on ischemic retinol function. Exp Eye Res. 64:1997;559.
65. West S., Vitale S., Hallfrisch J., et al. Are antioxidants a supplement protective for age-related ocular degeneration? Arch Opthalmol. 112:1994;222.
66. MacEvilly C.J., Muller D.P.R. Lipid peroxidation in neural tissues and fractions from vitamin E-deficient rats. Free Radic Biol Med. 20:1996;639.
67. Tohgi H., Abe T., Saheki M., Yumazaki K., Takahashi S. Alpha-tocopherol quinone level is remarkably lower in cerebral spinal fluid of patients with sporadic amyotrophic lateral sclerosis. Neurosci Lett. 5:207:1996.
68. Dexter D.T., Nanayakkara I., Goss-Sampson M.A., et al. Nigral dopaminergic cell loss in vitamin E-deficient rats. Neuroreport. 5:1994;1773.
69. Tohgi H., Abe T., Saheki M., Hamato F., Susaki K., Takahashi S. Reduced and oxidized forms of glutathione and alpha-tocopherol in the cerebrospinal fluid of Parkinsonism patients-comparison between before and after L-DOPA treatment. Neurosci Lett. 184:1995;21.
70. Shin S.M., Razdan B., Mishra O.P., Johnson L., Delivoriapapadopoulos M. Protective effect of α-tocopherol on brain cell membrane function during cerebral cortical hypoxia in newborn piglets. Brain Res. 653:1994;45.
71. Kay P., Tesh R., Woo J., Chin D., Muk Y.T. Serum vitamin E concentration in adult-onset spinocerebellar degeneration. J Neurol Neurosurg Psychiatry. 52:1989;131.
72. Traber M.F., Sokol R.J., Ringel S.P., Neville H.E., Thellman C.A., Kayden H.J. Lack of tocopherol in peripheral nerves of vitamin E deficiency patients with peripheral neuropathy. N Engl J Med. 317:1987;262.
73. Seddon J.M., Umed A.A., Spisduto R.D., et al. Dietary carotenoid, vitamins A, C and E, and age-related macular degeneration. JAMA. 272:1994;1413.
74. Moran J., Salazar P., Pasantes-Morales H. Effect of tocopherol and taurine on membrane fluidity of retinal rod outer segments. Exp Eye Res. 45:1987;769.
75. Tyurin V.A., Korolkov S.N., Berman A.L., Kagan V.E. Vitamin E-induced structural stabilization of lipids and rhodopsin in photoreceptor membranes. Byull Ekop Biol Med. 103:1987;391.
76. Henkin R.I. Taste in man. Harrison D., Hinchcliffe R. Scientific foundations of otolaryngology. 1976;469 Wm Heinemann Medical Books, London.
77. Schwob J.E. The biochemistry of olfactory neurons stages of differentiation and neuronal subsets . Serby M.L., Chodor K.L. Science of olfaction. 1992;80 Springer-Verlag, New York.
78. Pace U., Hanski E., Salomon Y., Lancet D. Odorant sensitive adenylate cyclase may mediate olfactory reception. Nature. 316:1985;255.
79. Dawson T.M., Arriza I.L., Jaworsky D.E., et al. β-Adrenergic receptor kinase-2 and β-arrestin-2 as mediators of odorant-induced desensitization. Science. 259:1993;825.
80. Anholt R.R.H. Molecular neurobiology of olfaction. Crit Rev Neurobiol. 7:1993;1.
81. Bakalyar H.A., Reed R.R. Identification of a specialized adenyl cyclase that may mediate odorant detection. Science. 250:1990;1403.
82. Ludwig J., Margalit T., Eismann E., Lancet D., Kaupp U.B. Primary structure of cAMP-gated channel from bovine olfactory epithelium. FEBS Lett. 270:1990;24.
83. Dhallan R.S., Yau K.W., Schrader K.A., Reed R.R. Primary structure and functional expression of a cyclic nucleotide-gated channel from olfactory neurons. Nature. 347:1990;184.
84. Firestein S., Zufall F., Shepherd G.M. Single odor-sensitive channels in olfactory receptor neurons are also gated by cyclic nucleotides. J Neurosci. 11:1991;3565.
85. Lazard D., Zupke K., Poria Y., Lancet D. Odorant signal termination by olfactory UDP glucuronosyl transferase. Nature. 349:1991;790.
86. Frings S., Lindemann B. Current recording from sensory cilia of olfactory receptor cells in situ. I. The neuronal response to cyclic nucleotides. J Gen Physiol. 97:1991;1.
87. Henkin R.I. Development of human chemosensation the role of the stomal area, its biochemistry and relationship to otolaryngology . Folia Otorhinolaryngol Pathol Respir. 3:1997;43.
88. Henkin R.I., Doherty A.E., Martin B.M. Nasal seroproteins a new frontier in the exploration of physiology and pathology of nasal and sinus disease . Veldman J.E., Passali D., Lim D.J. New frontiers in immunobiology. 2000;127 Kugler, The Hague.
89. Henkin R.I. Drug induced taste and smell disorders incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction . Drug Safety. 11:1994;310.
90. Cousins R.J. Metal elements and gene expression. Annu Rev Nutr. 14:1994;449.
91. Kalmus H., Farnsworth D. Impairment and recovery of taste following irradiation of the oropharynx. J Laryngol Otol. 73:1959;18.
92. Mossman K.L., Henkin R.I. Radiation-induced changes in taste acuity in cancer patients. Int J Radiat Oncol Biol Phys. 4:1978;663.
93. Henkin R.I., Talal N., Larson A.L., Mattern C.F.T. Abnormalities of taste and smell in Sjogren's syndrome. Ann Intern Med. 76:1972;375.
94. Catalanotto F.A., Frank M.E., Contreas R.J. Animal models of taste alteration. Meiselman H.L., Rifkin R.S. Clinical measurements of taste and smell. 1986;429 Macmillan, New York.
95. Gomez-Ramos P., Rodriguez-Echandia E.L. The fine structural effect of sialectomy on the taste bud cell in the rat. Tissue Cell. 11:1979;19.
96. Cano J., Rodriguez-Echandes E.L. Degenerating taste buds in sialectomized rats. Acta Anat. 106:1980;487.
97. Henkin R.I. Taste localization in man. Bosma J.F. Oral sensation and perception, Vol II. 1969;43 CC Thomas, Springfield, IL.
98. Henkin R.I. The definition of primary and accessory areas of olfaction as the basis for a classification of decreased olfactory acuity. Hayashi T. Olfaction and taste, Vol II. 1967;235 Pergamon Press, London.
99. Zilstorff K., Herbild O. Parosmia. Acta. Otolaryngol. 360:(suppl):1979;40.
100. Thatcher B.J., Doherty A.E., Orvisky E., Martin B.M., Henkin R.I. Gustin from human parotid saliva is carbonic anhydrase VI. Biochem Biophys Res Commun. 250:1998;635.
101. Levy L.M., Henkin R.I., Hutter A., Lin C.S., Schellinger D. Increased brain activation in response to odors in patients with hyposmia after theophylline treatment demonstrated by fMRI. J Comput Asst Tomog. 22:1998;760.
102. Wistrand PJ. The use of carbonic anhydrase inhibitors in ophthalmology and clinical medicine. Ann NY Acad Sci 1984;424:609.
103. Joyce P.W. Taste disturbance with acetazolamide. Lancet. 336:1990;1446.
104. Kirsner J.B., Henkin R.I. Sulfamethazine-related dysgeusia. JAMA. 241:1979;837.
105. Topiramate (Topamax). In: Physicians' desk reference. Montvale, NJ: Medical Economics, 2001:2391.
106. Balfour J.A., Wilde M.I. Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension. Drugs Aging. 10:1997;384.
107. Sutherland G.R., Baker E., Fernandez D.F., et al. The gene for human carbonic anhydrase VI (CA 6) is on the tip of the short arm of chromosome 1. Cytogenet Cell Genet. 50:1989;149.
108. McConnell R.J., Menedez C.W., Smith F.R., Henkin R.I., Rivlin R.S. Defects of taste and smell in patients with hypothyroidism. Am J Med. 59:1975;354.
109. Rivlin R.S., Osnos M., Rosenthal S., Henkin R.I. Abnormalities in taste preferences in hypothyroid rats. Am J Physiol. 1:1977;E80.
110. Henkin R.I. Effects of ACTH, adrenocorticosteroids and thyroid hormone on sensory function. Stumpf W.E., Grant L.D. Anatomical neuroendocrinology. 1975;298 Karger AG, Basel.
111. Levi-Montalcini R, Angeletti PU. Nerve growth factor. In: Sreebny M, Meyer L, eds. Salivary gland and its secretion. Oxford: Pergamon Press, 1964:129.
112. Aloe L., Levi-Montalcini R. Comparative studies on testosterone and L-thyroxine effect on the synthesis of nerve growth factor in mouse submaxillary salivary glands. Exp Cell Res. 125:1980;15.
113. Henkin R.I., Law J.S., Nelson N.R. The role of zinc on the trophic growth factors nerve growth factor and gustin. Hurley L.S., Keen C.L., Lonnerdal B., Rucker R.B. Trace elements in man and animals, Vol 6. 1988;385 Plenum Press, New York.
114. Lum C.Y.K., Henkin R.I. Binding of mouse 2.5S nerve growth factor (NGF) to purified bovine taste bud membranes (TBM) a new radioreceptor assay for NGF . Fed Proc. 36:1977;968.
115. Henkin R.I. Zinc, saliva and taste interrelationships of gustin, nerve growth factor, saliva and zinc . Hambidge K.M., Nichols B.L. Zinc and copper in clinical medicine. 1978;35 Spectrum, Jamaica, NY.
116. Rydel R.E., Greene L.A. cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc Natl Acad Sci USA. 85:1988;1257.
117. Sunderman F.W. Jr. The influence of zinc on apoptosis. Ann Clin Lab Sci. 25:1995;134.
118. Yamada T., Ohyama H. Radiation-induced interphase death of rat thymocytes is internally programmed (apoptosis). Int J Radiat Biol Relat Stud Phys Chem Med. 53:1988;65.
119. Harms-Ringdahl M., Nicotera P., Radford I.R. Radiation induced apoptosis. Mutat Res. 366:1996;171.
120. Woodgate A.M., Dragunow M. Apoptosis of nerve cells. Exp Pharmacol. 142:2000;197.
121. Chen J., Zhu R.I., Nakayama K., et al. Expression of apoptosis-effector gene, Bax, is up-regulated in vulnerable hippocampal CA1 neurons following global ischemia. J Neurochem. 67:1996;64.
122. Azzi A., Stocker A. Vitamin E. non-antioxidant effects. Prog Lipid. Res. 39:2000;231.
123. Azzi A. Personal communication 2000.
124. Copp R.P., Wisniewski T., Hentati F., Larnout A., BenHamida M., Kayden N.J. Localization of α-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders. Brain Res. 822:1999;80.
125. Tasinato A., Boscoboinik D., Bartoli G.M., Maroni P., Azzi A. d-α-Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc Natl Acad Sci USA. 92:1995;12190.
126. Chan A.C., Tran K. The uptake of (R, R, R) alpha-tocopherol by human endothelial cells in culture. Lipids. 25:1990;17.
127. Azzi A. Alpha-tocopherol and signalling in smooth muscle cells. FASEB J. 14:2000;54.
128. Ricciarelli R., Tasinato A., Clement S., Özer N.K., Boscoboinik D., Azzi A. α-Tocopherol specifically inactivates cellular protein kinase C by changing its phosphorylation site. Biochem J. 334:1998;243.
129. Packer L. Molecular aspects of α-tocotrienol antioxidant action and cell signalling. FASEB J. 14:2000;A245.
130. Satoh K., Ida Y., Hosaka M., et al. Induction of apoptosis by cooperative action of vitamins C and E. Anticancer Res. 18:1998;4371.
131. Kline K., Yu W., Sanders B.G. Vitamin E mechanisms of action as tumor cell growth inhibitors . J Nutr. 131:2001;1615.
132. Tagami M., Ikeda K., Yamagata K., et al. Vitamin E prevents apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rata. Lab Invest. 79:1999;609.
133. Tagami M., Yamagata K., Ikeda K., et al. Vitamin E prevents apoptosis in cortical neurons during hypoxia and oxygen reperfusion. Lab Invest. 78:1998;1415.
134. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med. 23:1997;134.
135. Multhaup G., Ruppert T., Schlicksupp A., et al. Reactive oxygen species and Alzheimer's disease. Biochem Pharmacol. 54:1997;533.
136. Doty R.L., Reyes P.F., Gregor T. Presence of both odor identification and detection defects in Alzheimer's disease. Brain Res Bull. 18:1987;597.
137. Henkin R.I. Olfactory dysfunction in Alzheimer's disease. Lancet. 355:2000;1014.
138. Schroeder D.J., Hart L.L., Miyagi S.L. Vitamin E in tardive dyskinesia. Ann Pharmacother. 27:1993;311.
139. Cadet J.L., Kahler L.A. Free radical mechanisms in schizophrenia and tardive dyskinesia. Neurosci Biobehav Rev. 18:1994;457.
140. deRijk M.C., Breteler M.M.B., den Breeijen J.H., et al. Dietary antioxidants and Parkinson's disease. Arch Neurol. 54:1997;762.
141. Golbe L.I., Farrell T.M., Davis P.H. Case-control study of early life dietary factors in Parkinson's disease. Arch Neurol. 45:1988;1350.
142. Doty R.L., Riklan M., Deems D.A., Reynolds C., Stellar S. The olfactory and cognitive deficits in Parkinson's disease evidence for independence . Ann Neurol. 25:1989;166.
143. Vatassery G.T., Bauer T., Dysken M. High doses of vitamin E in the treatment of disorders of the central nervous system in the aged. Am J Clin Nutr. 70:1999;793.
144. Sano M., Ernesto C., Thomas R.G., Klanber M.A. A controlled trial of selegiline, alpha tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med. 336:1997;1216.
145. Drachman D.A., Leber P. Treatment of Alzheimer's disease searching for a breakthrough, settling for less . N Engl J Med. 336:1997;1245.
146. Lohr J.B., Caligiuri M.P. A double-blind placebo controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiatry. 57:1996;167.
147. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med. 328:1993;176.